VX-765

VX-765

CAT N°: 28825
Price:

From 92.00 78.20

VX-765 is a prodrug form of the caspase-1 inhibitor VRT-043198.{45582} VX-765 (50, 100, and 200 mg/kg) inhibits LPS-induced increases in serum IL-1? levels in mice. It also reduces oxazolone-induced ear edema and levels of IL-1?, IL-18, and IFN-? in ear tissue in an oxazolone-sensitized mouse model of delayed-type hypersensitivity. VX-765 reduces forepaw inflammation in a mouse model of collagen-induced arthritis in a dose-dependent manner. VX-765 (?50 mg/kg) decreases seizure duration and the number of seizures in a mouse model of acute seizures induced by hippocampal kainic acid injection, as well as delays the onset of seizures when administered at doses of 100 and 200 mg/kg.{45583} It also reduces the aggregated duration of epileptic activity in a mouse model of chronic epilepsy.

We also advise you